Stokes Capital Advisors LLC decreased its stake in shares of Danaher Co. (NYSE:DHR) by 6.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,090 shares of the conglomerate’s stock after selling 1,300 shares during the period. Danaher comprises 2.1% of Stokes Capital Advisors LLC’s portfolio, making the stock its 14th largest holding. Stokes Capital Advisors LLC’s holdings in Danaher were worth $4,326,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently modified their holdings of the company. Provident Wealth Management LLC bought a new position in Danaher during the third quarter valued at approximately $27,000. Howe & Rusling Inc. increased its holdings in Danaher by 81.4% during the second quarter. Howe & Rusling Inc. now owns 156 shares of the conglomerate’s stock valued at $28,000 after buying an additional 70 shares during the last quarter. Semmax Financial Advisors Inc. purchased a new stake in Danaher during the second quarter valued at approximately $35,000. Trustcore Financial Services LLC increased its holdings in Danaher by 36.9% during the second quarter. Trustcore Financial Services LLC now owns 230 shares of the conglomerate’s stock valued at $41,000 after buying an additional 62 shares during the last quarter. Finally, Prestige Wealth Management Group LLC increased its holdings in Danaher by 1,055.6% during the first quarter. Prestige Wealth Management Group LLC now owns 312 shares of the conglomerate’s stock valued at $43,000 after buying an additional 285 shares during the last quarter. Institutional investors own 78.01% of the company’s stock.
In other Danaher news, CEO Thomas Patrick Joyce, Jr. sold 181,394 shares of the stock in a transaction on Friday, July 24th. The shares were sold at an average price of $193.98, for a total transaction of $35,186,808.12. Following the completion of the transaction, the chief executive officer now owns 285,569 shares in the company, valued at $55,394,674.62. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Angela S. Lalor sold 77,909 shares of the stock in a transaction on Monday, August 31st. The shares were sold at an average price of $205.50, for a total transaction of $16,010,299.50. Following the transaction, the senior vice president now owns 52,445 shares of the company’s stock, valued at approximately $10,777,447.50. The disclosure for this sale can be found here. Insiders have sold 530,474 shares of company stock valued at $104,501,669 over the last ninety days. 11.70% of the stock is currently owned by corporate insiders.
DHR opened at $227.45 on Friday. The stock has a market capitalization of $161.36 billion, a price-to-earnings ratio of 48.70, a PEG ratio of 3.52 and a beta of 0.88. The company has a fifty day moving average of $209.83 and a 200 day moving average of $183.29. Danaher Co. has a fifty-two week low of $119.60 and a fifty-two week high of $229.45. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.74 and a current ratio of 2.20.
Danaher (NYSE:DHR) last posted its earnings results on Thursday, July 23rd. The conglomerate reported $1.44 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.09 by $0.35. The company had revenue of $5.30 billion during the quarter, compared to analysts’ expectations of $5.01 billion. Danaher had a net margin of 17.73% and a return on equity of 11.88%. Danaher’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period last year, the company posted $1.09 earnings per share. On average, equities research analysts forecast that Danaher Co. will post 5.48 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, September 28th will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Friday, September 25th. This represents a $0.72 annualized dividend and a yield of 0.32%. Danaher’s payout ratio is 16.29%.
A number of brokerages have commented on DHR. Zacks Investment Research raised shares of Danaher from a “hold” rating to a “buy” rating and set a $203.00 target price for the company in a report on Tuesday, July 21st. Royal Bank of Canada upped their target price on shares of Danaher from $205.00 to $218.00 and gave the company an “outperform” rating in a report on Friday, July 24th. Wells Fargo & Company reaffirmed a “buy” rating and set a $234.00 target price on shares of Danaher in a report on Tuesday, September 29th. UBS Group upped their target price on shares of Danaher from $176.00 to $233.00 and gave the company a “buy” rating in a report on Monday, July 27th. Finally, Jefferies Financial Group increased their price objective on shares of Danaher from $190.00 to $230.00 and gave the stock a “buy” rating in a research note on Friday, July 24th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $202.00.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
See Also: Limitations to arbitrage trading
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.